Evelo Biosciences Inc logo

Evelo Biosciences Inc

NEW
OTCPK:EVLO (USA)  
$ 0.00010 -0.000099 (-99%) 10:08 PM EST
At Loss
Volume:
0
Avg Vol (2M):
3.50K
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
3.50K

Business Description

Evelo Biosciences Inc logo
Evelo Biosciences Inc
NAICS : 325411 SIC : 2833
ISIN : US2997342025
Description
Evelo Biosciences Inc is a clinical-stage biotechnology company focused on discovering and developing a new class of oral medicines that act on immune cells in the small intestine with systemic effects. The company is developing EDP1815 as a treatment in psoriasis and atopic dermatitis and EDP2939 in psoriasis.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
33.86
9-Day RSI
41.19
14-Day RSI
43.86
6-1 Month Momentum %
-80
12-1 Month Momentum %
-80

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History

GF Valueâ„¢

Evelo Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Evelo Biosciences Inc Stock Events

Financials Calendars
Event Date Price ($)
Third quarter earnings results for 2026 2026-11-13 In 139 days
Second quarter earnings results for 2026 2026-08-20 In 54 days
Annual report for 2025 2026-07-01 In 4 days
First quarter earnings results for 2026 2026-07-01 In 4 days
General meeting for 2025 2026-06-30 In 3 days
0.05:1 Stock Split 2023-06-30 3.53 (-7.45%)
Show
Entries

Guru Commentaries on OTCPK:EVLO

No articles.

Articles on Evelo Biosciences Inc

No articles.

Headlines

See More
  • 1
No news.
  • 1